Back to Journals » Neuropsychiatric Disease and Treatment » Volume 6 » Issue 1

Review

Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patients

          
Total article views   Abstract views HTML views PDF downloads Totals
15,232 Dovepress* 11,546 487+ 2,165 12,033
PubMed Central* 20 3,179 743 3,199
Totals 11,566 3,666 2,908 15,232
*Since 10 November 2010
+Since July 2016

View citations on PubMed Central and Google Scholar